Nitsch; Roger

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nitsch; Roger.The latest application filed is for "human anti-sod1 antibodies".

Company Profile

14.35.70

Nitsch; Roger - Zumikon CH
NITSCH; Roger - Zumlkon CH
Nitsch; Roger - Zollikon CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human Anti-SOD1 Antibodies App 20220267471 - Montrasio; Fabio ; et al.	2022-08-25
Human anti-SOD1 antibodies Grant 11,352,441 - Montrasio , et al. June 7, 2	2022-06-07
Method Of Providing Patient Specific Immune Response In Amyloidoses And Protein Aggregation Disorders App 20210361754 - HENCO; Karsten ; et al.	2021-11-25
TDP-43 specific binding molecules Grant 11,091,540 - Nitsch , et al. August 17, 2	2021-08-17
Human Anti-Tau Antibodies App 20210238265 - Nitsch; Roger ; et al.	2021-08-05
Compounds And Methods For Use In The Treatment Of Microglia-mediated Disorders App 20210000807 - FISHER; Abraham ; et al.	2021-01-07
Method of providing patient specific immune response in amyloidoses and protein aggregation disorders Grant 10,874,725 - Henco , et al. December 29, 2	2020-12-29
Human anti-alpha-synuclein antibodies Grant 10,703,808 - Weihofen , et al.	2020-07-07
TDP-43 Specific Binding Molecules App 20200017577 - Nitsch; Roger ; et al.	2020-01-16
Human Anti-SOD1 Antibodies App 20190284302 - Montrasio; Fabio ; et al.	2019-09-19
Method Of Providing Disease-specific Binding Molecules And Targets App 20190263896 - Nitsch; Roger ; et al.	2019-08-29
Human Anti-Tau Antibodies App 20190233506 - Nitsch; Roger ; et al.	2019-08-01
Human anti-SOD1 antibodies Grant 10,344,097 - Montrasio , et al. July 9, 2	2019-07-09
Anti-alpha synuclein binding molecules Grant 10,301,381 - Weihofen , et al.	2019-05-28
Method Of Providing Disease-specific Binding Molecules And Targets App 20190153082 - Nitsch; Roger ; et al.	2019-05-23
TDP-43 specific binding molecules Grant 10,259,866 - Nitsch , et al.	2019-04-16
Method of providing disease-specific binding molecules and targets Grant 10,202,445 - Nitsch , et al. Feb	2019-02-12
Human Anti-Alpha-Synuclein Antibodies App 20180371065 - Weihofen; Andreas ; et al.	2018-12-27
Anti-Alpha Synuclein Binding Molecules App 20180355027 - Weihofen; Andreas ; et al.	2018-12-13
Methods of treating Alzheimer's disease Grant 10,131,708 - Nitsch , et al. November 20, 2	2018-11-20
Anti-alpha synuclein binding molecules Grant 9,975,947 - Weihofen , et al. May 22, 2	2018-05-22
Method of Providing Disease-Specific Binding Molecules and Targets App 20180134773 - Nitsch; Roger ; et al.	2018-05-17
Method Of Providing Patient Specific Immune Response In Amyloidoses And Protein Aggregation Disorders App 20180110845 - HENCO; Karsten ; et al.	2018-04-26
Human anti-alpha-synuclein antibodies Grant 9,896,504 - Weihofen , et al. February 20, 2	2018-02-20
Human Anti-Tau Antibodies App 20180002409 - Nitsch; Roger ; et al.	2018-01-04
Novel Anti-fibroblast Activation Protein (fap) Antibodies And Uses Derived Thereof App 20170369592 - BROKOPP; Chad ; et al.	2017-12-28
Method of providing disease-specific binding molecules and targets Grant 9,828,420 - Nitsch , et al. November 28, 2	2017-11-28
Method Of Providing Disease-specific Binding Molecules And Targets App 20170283491 - Nitsch; Roger ; et al.	2017-10-05
Anti-Alpha Synuclein Binding Molecules App 20170233463 - Weihofen; Andreas ; et al.	2017-08-17
Method of providing disease-specific binding molecules and targets Grant 9,670,272 - Nitsch , et al. June 6, 2	2017-06-06
TDP-43 Specific Binding Molecules App 20170152308 - Nitsch; Roger ; et al.	2017-06-01
Human anti-tau antibodies Grant 9,605,059 - Nitsch , et al. March 28, 2	2017-03-28
TDP-43 specific binding molecules Grant 9,587,014 - Nitsch , et al. March 7, 2	2017-03-07
Anti-.alpha. synuclein binding molecules Grant 9,580,493 - Weihofen , et al. February 28, 2	2017-02-28
Method Of Providing Patient Specific Immune Response In Amyloidoses And Protein Aggregation Disorders App 20160354451 - Henco; Karsten ; et al.	2016-12-08
Method of Providing Disease-Specific Binding Molecules and Targets App 20160289310 - Nitsch; Roger ; et al.	2016-10-06
Human Anti-alpha-synuclein Antibodies App 20160244515 - Weihofen; Andreas ; et al.	2016-08-25
Method of providing patient specific immune response in amyloidoses and protein aggregation disorders Grant 9,370,531 - Henco , et al. June 21, 2	2016-06-21
Human Anti-SOD1 Antibodies App 20160168267 - Montrasio; Fabio ; et al.	2016-06-16
Human anti-SOD1 antibodies Grant 9,283,271 - Montrasio , et al. March 15, 2	2016-03-15
Humanized antibodies against the beta-amyloid peptide Grant 9,273,126 - Ewert , et al. March 1, 2	2016-03-01
Human Anti-tau Antibodies App 20150252102 - NITSCH; ROGER ; et al.	2015-09-10
Human Anti-alpha-synuclein Antibodies App 20150232542 - WEIHOFEN; Andreas ; et al.	2015-08-20
Method Of Providing Disease-specific Binding Molecules And Targets App 20150147343 - NITSCH; Roger ; et al.	2015-05-28
Human anti-tau antibodies Grant 8,940,272 - Nitsch , et al. January 27, 2	2015-01-27
Human anti-alpha-synuclein antibodies Grant 8,940,276 - Weihofen , et al. January 27, 2	2015-01-27
Anti-Alpha Synuclein Binding Molecules App 20140369940 - Weihofen; Andreas ; et al.	2014-12-18
Method of providing disease-specific binding molecules and targets Grant 8,906,367 - Nitsch , et al. December 9, 2	2014-12-09
Human Anti-sod1 Antibodies App 20140301945 - Montrasio; Fabio ; et al.	2014-10-09
Ankyrin G And Modulators Thereof For The Treatment Of Neurodegenerative Disorders App 20140044644 - Santuccione Chadha; Antonella ; et al.	2014-02-13
Humanized Antibodies Against The Beta-amyloid Peptide App 20130345292 - Ewert; Stefan ; et al.	2013-12-26
Human Anti-tau Antibodies App 20130295021 - Chen; Feng ; et al.	2013-11-07
Method of Providing Disease-Specific Binding Molecules and Targets App 20130266585 - NITSCH; Roger ; et al.	2013-10-10
Method of Providing Disease-Specific Binding Molecules and Targets App 20130266514 - NITSCH; Roger ; et al.	2013-10-10
Method of Providing Disease-Specific Binding Molecules and Targets App 20130266586 - NITSCH; Roger ; et al.	2013-10-10
Monoclonal human tumor-specific antibody Grant 8,519,106 - Esslinger , et al. August 27, 2	2013-08-27
Method Of Providing Disease-specific Binding Molecules And Targets App 20130216555 - NITSCH; Roger ; et al.	2013-08-22
Humanized antibodies against the .beta.-amyloid peptide Grant 8,323,647 - Ewert , et al. December 4, 2	2012-12-04
Human Anti-Tau Antibodies App 20120087861 - Nitsch; Roger ; et al.	2012-04-12
Human Anti-Alpha-Synuclein Antibodies App 20110300077 - Weihofen; Andreas ; et al.	2011-12-08
Transgenic animal model for alzheimer's disease Grant 8,022,268 - Grimm , et al. September 20, 2	2011-09-20
Method of Promoting Neurogenesis App 20110182809 - Nitsch; Roger ; et al.	2011-07-28
Method Of Providing Human Tumor-specific Antibodies App 20110123447 - Esslinger; Christoph ; et al.	2011-05-26
Use Of Phosphatase Inhibitors For The Treatment Of Neurodegenerative Diseases App 20110086908 - Nitsch; Roger ; et al.	2011-04-14
Humanized Antibodies Against The Beta-amyloid Peptide App 20110020220 - Ewert; Stefan ; et al.	2011-01-27
Monoclonal Human Tumor-specific Antibody App 20100330075 - Esslinger; Christoph ; et al.	2010-12-30
Method Of Providing Patient Specific Immune Response In Amyloidoses And Protein Aggregation Disorders App 20100297108 - Henco; Karsten ; et al.	2010-11-25
Moncolonal Amyloid Beta (abeta) - Specific Antibody And Uses Thereof App 20100239570 - Nitsch; Roger	2010-09-23
Method of Providing Disease-Specific Binding Molecules and Targets App 20100202968 - Nitsch; Roger ; et al.	2010-08-12
Noveltreatment For Neurological Disorders App 20100172919 - Grimm; Jan ; et al.	2010-07-08
Means And Methods For Isolating And Determining Novel Targets For The Treatment Of Neurodegenerative, Neurological Or Neuropsychiatric Disorders And Compositions Comprising The Same App 20100169988 - Kohli; Bernhard ; et al.	2010-07-01
Use Of Phosphatase Inhibitors For The Treatment Of Neurodegenerative Diseases App 20100048687 - Nitsch; Roger ; et al.	2010-02-25
Inducing neurofibrillary tangles in transgenic mice expressing a mutant tau protein Grant 7,550,648 - Gotz , et al. June 23, 2	2009-06-23
Transgenic animal model for alzheimer's disease App 20090117120 - Grimm; Jan ; et al.	2009-05-07
Methods of diagnosing or prognosing Alzheimer's disease App 20090023145 - Nitsch; Roger ; et al.	2009-01-22
Method of inducing the formation of neurofibrillary tangles in transgenic animals App 20080261878 - Gotz; Jurgen ; et al.	2008-10-23
Methods of diagnosing or treating neurological diseases and cell degeneration App 20080261302 - Nitsch; Roger ; et al.	2008-10-23
Methods of dignosing or treating depression on basis of increased cerebrospinal fluid levels of neurotrodhin 3 App 20080188435 - Nitsch; Roger ; et al.	2008-08-07
Methods of diagnosing or prognosticating age-related macular degeneration App 20070117122 - Richard; Giesbert ; et al.	2007-05-24
Method of monitoring immunotherapy App 20060240485 - Hock; Christoph ; et al.	2006-10-26
Methods and compounds for treating brain amyloidosis App 20060142194 - Nitsch; Roger ; et al.	2006-06-29
Methods of diagnosing or treating neurological diseases and cell degeneration App 20050239169 - Nitsch, Roger ; et al.	2005-10-27
Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determining single nucleotide polymorphisms App 20050177881 - Papassotiropoulos, Andreas ; et al.	2005-08-11
Methods of diagnosing or treating Alzheimer's disease on basis of increased cerebrospinal fluid levels of nerve growth factor App 20050130233 - Nitsch, Roger ; et al.	2005-06-16
Polymorphism of soati useful for identifying risk of developing alzheimer's disease App 20050130165 - Papasotiropoulos, Andreas ; et al.	2005-06-16
Method of inducing the formation of neurofibrillary tangles in transgenic animals App 20050015819 - Gotz, Jurgen ; et al.	2005-01-20
Methods and compounds for treating brain amyloidosis App 20040038302 - Nitsch, Roger ; et al.	2004-02-26
Muscarinic M1 agonist as an inhibitor of beta-amyloid (A.beta.40 and A.beta.42)-synthesis Grant 6,573,276 - Hock , et al. June 3, 2	2003-06-03
Muscarinic M1 agonist as an inhibitor of beta-amyloid (ABeta40 and ABeta42)-synthesis App 20030050221 - Hock, Christoph ; et al.	2003-03-13